Concepts (302)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium-Binding Proteins | 14 | 2016 | 114 | 2.080 |
Why?
|
| Sphingolipids | 5 | 2021 | 337 | 0.670 |
Why?
|
| Neural Crest | 2 | 2016 | 58 | 0.650 |
Why?
|
| Breathing Exercises | 1 | 2016 | 8 | 0.580 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2016 | 7 | 0.580 |
Why?
|
| Yoga | 1 | 2016 | 18 | 0.570 |
Why?
|
| Meditation | 1 | 2016 | 33 | 0.560 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 176 | 0.550 |
Why?
|
| Biomarkers | 4 | 2021 | 1593 | 0.550 |
Why?
|
| Integrin beta1 | 2 | 2015 | 48 | 0.540 |
Why?
|
| Saliva | 1 | 2016 | 142 | 0.530 |
Why?
|
| Alternative Splicing | 1 | 2015 | 93 | 0.500 |
Why?
|
| Placenta | 1 | 2015 | 101 | 0.490 |
Why?
|
| Inflammation | 2 | 2019 | 1030 | 0.480 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 45 | 0.460 |
Why?
|
| Bioprosthesis | 1 | 2013 | 101 | 0.440 |
Why?
|
| Tissue Scaffolds | 1 | 2013 | 111 | 0.430 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 144 | 0.430 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2013 | 182 | 0.420 |
Why?
|
| Extracellular Matrix Proteins | 5 | 2015 | 144 | 0.410 |
Why?
|
| Lipoproteins, LDL | 4 | 2012 | 343 | 0.310 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2021 | 756 | 0.310 |
Why?
|
| ADAM Proteins | 4 | 2012 | 53 | 0.290 |
Why?
|
| Cells, Cultured | 8 | 2016 | 2673 | 0.290 |
Why?
|
| Cell Movement | 4 | 2015 | 630 | 0.280 |
Why?
|
| Fibronectins | 3 | 2015 | 130 | 0.250 |
Why?
|
| Antigen-Antibody Complex | 3 | 2010 | 175 | 0.250 |
Why?
|
| Integrin alpha5beta1 | 2 | 2015 | 9 | 0.240 |
Why?
|
| Telomere | 2 | 2013 | 59 | 0.230 |
Why?
|
| Aorta | 2 | 2013 | 316 | 0.200 |
Why?
|
| Podocytes | 2 | 2020 | 113 | 0.200 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 83 | 0.190 |
Why?
|
| Cytokines | 2 | 2016 | 866 | 0.190 |
Why?
|
| Membrane Proteins | 2 | 2016 | 617 | 0.190 |
Why?
|
| Down-Regulation | 1 | 2001 | 447 | 0.180 |
Why?
|
| Chemokine CCL11 | 1 | 2019 | 9 | 0.180 |
Why?
|
| Nanowires | 1 | 2019 | 11 | 0.180 |
Why?
|
| Extracellular Matrix | 2 | 2015 | 493 | 0.180 |
Why?
|
| Zinc Oxide | 1 | 2019 | 18 | 0.180 |
Why?
|
| Humans | 28 | 2021 | 68525 | 0.180 |
Why?
|
| Pregnancy | 2 | 2016 | 2331 | 0.180 |
Why?
|
| Eosinophils | 1 | 2019 | 60 | 0.180 |
Why?
|
| CHO Cells | 2 | 2015 | 161 | 0.180 |
Why?
|
| Morphogenesis | 2 | 2011 | 158 | 0.180 |
Why?
|
| Animals | 16 | 2019 | 20877 | 0.180 |
Why?
|
| Macrophages | 3 | 2019 | 647 | 0.180 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 118 | 0.170 |
Why?
|
| Lipoproteins | 1 | 2020 | 161 | 0.170 |
Why?
|
| Transcriptome | 1 | 2020 | 164 | 0.160 |
Why?
|
| Mice | 12 | 2019 | 8472 | 0.160 |
Why?
|
| Mice, Knockout | 4 | 2016 | 1692 | 0.150 |
Why?
|
| Embryo Loss | 1 | 2016 | 17 | 0.140 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 65 | 0.140 |
Why?
|
| Surface Plasmon Resonance | 1 | 2016 | 50 | 0.140 |
Why?
|
| Myosin Type I | 1 | 2016 | 20 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2019 | 326 | 0.140 |
Why?
|
| Protein Isoforms | 2 | 2015 | 246 | 0.140 |
Why?
|
| Ceramides | 1 | 2020 | 578 | 0.140 |
Why?
|
| Female | 11 | 2021 | 38015 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2020 | 2688 | 0.140 |
Why?
|
| Cricetulus | 1 | 2015 | 98 | 0.130 |
Why?
|
| Lipoproteins, HDL | 2 | 2008 | 113 | 0.120 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 938 | 0.120 |
Why?
|
| Porosity | 1 | 2013 | 63 | 0.120 |
Why?
|
| Hemochromatosis | 1 | 2013 | 13 | 0.120 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2013 | 24 | 0.110 |
Why?
|
| Transferrin | 1 | 2013 | 94 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2015 | 483 | 0.110 |
Why?
|
| Elastin | 1 | 2013 | 116 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2016 | 1341 | 0.110 |
Why?
|
| Carcinoma | 2 | 2004 | 215 | 0.100 |
Why?
|
| Mesangial Cells | 1 | 2012 | 37 | 0.100 |
Why?
|
| Life Change Events | 1 | 2013 | 223 | 0.100 |
Why?
|
| Mammary Arteries | 1 | 2011 | 18 | 0.100 |
Why?
|
| Protein Transport | 4 | 2016 | 280 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 201 | 0.100 |
Why?
|
| Iron | 1 | 2013 | 197 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2015 | 1173 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 102 | 0.100 |
Why?
|
| Collagen | 1 | 2013 | 636 | 0.090 |
Why?
|
| Lung | 1 | 2015 | 849 | 0.090 |
Why?
|
| Macrophage Activation | 1 | 2010 | 75 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2015 | 902 | 0.090 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2010 | 42 | 0.090 |
Why?
|
| Heart Ventricles | 2 | 2011 | 738 | 0.090 |
Why?
|
| Protein Binding | 5 | 2016 | 1027 | 0.090 |
Why?
|
| Fibrinogen | 1 | 2009 | 87 | 0.090 |
Why?
|
| Streptococcus pyogenes | 1 | 2009 | 20 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2009 | 82 | 0.080 |
Why?
|
| Blood Proteins | 1 | 2009 | 94 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 371 | 0.080 |
Why?
|
| Depressive Disorder, Major | 1 | 2013 | 438 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 442 | 0.080 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2008 | 63 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2011 | 1174 | 0.080 |
Why?
|
| Cell Adhesion | 2 | 2015 | 324 | 0.080 |
Why?
|
| Monocytes | 1 | 2008 | 210 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2009 | 204 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 247 | 0.070 |
Why?
|
| Lysophospholipids | 1 | 2008 | 209 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2009 | 244 | 0.070 |
Why?
|
| Cell Line | 2 | 2020 | 1752 | 0.070 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2006 | 36 | 0.070 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 39 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 3 | 2004 | 510 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2013 | 824 | 0.070 |
Why?
|
| Cattle | 2 | 2010 | 475 | 0.070 |
Why?
|
| Sphingosine | 1 | 2008 | 315 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2010 | 718 | 0.070 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2006 | 36 | 0.070 |
Why?
|
| Bioreactors | 1 | 2006 | 65 | 0.070 |
Why?
|
| Time Factors | 3 | 2021 | 4655 | 0.070 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 1533 | 0.070 |
Why?
|
| Male | 6 | 2021 | 37281 | 0.070 |
Why?
|
| Quality of Life | 1 | 2013 | 1515 | 0.070 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 1293 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2008 | 384 | 0.060 |
Why?
|
| Cell Survival | 3 | 2015 | 901 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2006 | 212 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 852 | 0.060 |
Why?
|
| Receptors, LDL | 2 | 2008 | 72 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 1465 | 0.060 |
Why?
|
| Adult | 6 | 2021 | 21375 | 0.060 |
Why?
|
| Genotype | 3 | 2013 | 785 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2013 | 1506 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1085 | 0.050 |
Why?
|
| Actomyosin | 1 | 2001 | 2 | 0.050 |
Why?
|
| Receptors, Fibronectin | 1 | 2001 | 6 | 0.050 |
Why?
|
| Cell Migration Inhibition | 1 | 2001 | 8 | 0.050 |
Why?
|
| Integrin alpha4 | 1 | 2001 | 3 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1548 | 0.050 |
Why?
|
| Sulfates | 1 | 2001 | 28 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 209 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2001 | 38 | 0.050 |
Why?
|
| Endocytosis | 2 | 1999 | 113 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2009 | 597 | 0.050 |
Why?
|
| Glycosaminoglycans | 1 | 2001 | 88 | 0.050 |
Why?
|
| Cricetinae | 1 | 2001 | 262 | 0.050 |
Why?
|
| Asymptomatic Diseases | 1 | 2021 | 43 | 0.050 |
Why?
|
| Heart | 1 | 2006 | 850 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1663 | 0.050 |
Why?
|
| In Vitro Techniques | 2 | 2019 | 765 | 0.050 |
Why?
|
| Chromatography, Affinity | 3 | 2009 | 73 | 0.050 |
Why?
|
| Chick Embryo | 1 | 2001 | 379 | 0.050 |
Why?
|
| Middle Aged | 5 | 2021 | 21119 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2001 | 230 | 0.050 |
Why?
|
| Mesoderm | 1 | 2001 | 231 | 0.050 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 125 | 0.050 |
Why?
|
| Myocardium | 1 | 2006 | 1204 | 0.050 |
Why?
|
| Carbon Isotopes | 1 | 2020 | 54 | 0.050 |
Why?
|
| Focal Adhesions | 1 | 2020 | 25 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 1 | 1999 | 11 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 42 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 112 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2011 | 150 | 0.040 |
Why?
|
| Endoderm | 1 | 1999 | 37 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2011 | 147 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1999 | 81 | 0.040 |
Why?
|
| U937 Cells | 2 | 2010 | 61 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 3702 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2019 | 101 | 0.040 |
Why?
|
| ADAMTS1 Protein | 2 | 2011 | 9 | 0.040 |
Why?
|
| Rats | 2 | 2012 | 5300 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2021 | 453 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 507 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 186 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 284 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 320 | 0.040 |
Why?
|
| Neutrophils | 1 | 2019 | 204 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2012 | 791 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 1999 | 370 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 248 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 244 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2019 | 330 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 1999 | 215 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2019 | 312 | 0.040 |
Why?
|
| Homeostasis | 1 | 2019 | 291 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2019 | 523 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2019 | 682 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 1997 | 81 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2020 | 1199 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 626 | 0.040 |
Why?
|
| Scattering, Small Angle | 1 | 2016 | 10 | 0.040 |
Why?
|
| X-Ray Diffraction | 1 | 2016 | 53 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 2093 | 0.030 |
Why?
|
| Point Mutation | 1 | 2016 | 97 | 0.030 |
Why?
|
| Glycoproteins | 1 | 1997 | 238 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 1997 | 190 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2008 | 492 | 0.030 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2015 | 2 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 5708 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 1425 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2264 | 0.030 |
Why?
|
| Binding Sites | 1 | 2016 | 631 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 742 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 126 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 546 | 0.030 |
Why?
|
| Hemochromatosis Protein | 1 | 2013 | 2 | 0.030 |
Why?
|
| Iron Overload | 1 | 2013 | 28 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 2790 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1640 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 1849 | 0.030 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2012 | 17 | 0.030 |
Why?
|
| ADAM17 Protein | 1 | 2012 | 28 | 0.030 |
Why?
|
| Physical Examination | 1 | 2013 | 152 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 180 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 207 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2550 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 56 | 0.030 |
Why?
|
| Thiophenes | 1 | 2012 | 76 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 166 | 0.030 |
Why?
|
| Immunoassay | 1 | 2011 | 64 | 0.030 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2011 | 54 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 521 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 146 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2011 | 128 | 0.020 |
Why?
|
| Child Abuse | 1 | 2013 | 186 | 0.020 |
Why?
|
| Endosomes | 1 | 2010 | 45 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 167 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 946 | 0.020 |
Why?
|
| Mitochondria | 1 | 2015 | 643 | 0.020 |
Why?
|
| Lysosomes | 1 | 2010 | 136 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2009 | 98 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1054 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2010 | 144 | 0.020 |
Why?
|
| Gelatin | 1 | 2009 | 14 | 0.020 |
Why?
|
| Antibodies | 1 | 2010 | 241 | 0.020 |
Why?
|
| Virulence | 1 | 2009 | 51 | 0.020 |
Why?
|
| Hemocyanins | 1 | 2008 | 14 | 0.020 |
Why?
|
| Foam Cells | 1 | 2008 | 26 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 2008 | 72 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 60 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2010 | 200 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2008 | 42 | 0.020 |
Why?
|
| Fetal Heart | 1 | 2008 | 41 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2008 | 88 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 434 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 188 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 1213 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 148 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 2083 | 0.020 |
Why?
|
| Kinetics | 2 | 1999 | 1047 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2006 | 21 | 0.020 |
Why?
|
| Versicans | 1 | 2006 | 44 | 0.020 |
Why?
|
| Body Patterning | 1 | 2006 | 44 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 296 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 331 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 498 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 28 | 0.020 |
Why?
|
| Chromatography | 1 | 2005 | 47 | 0.020 |
Why?
|
| Perfusion | 1 | 2006 | 131 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2005 | 78 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 189 | 0.020 |
Why?
|
| Catalysis | 1 | 2005 | 123 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 132 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2005 | 251 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2005 | 254 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2005 | 103 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2005 | 161 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3256 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 322 | 0.020 |
Why?
|
| Aged | 2 | 2011 | 14842 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 328 | 0.020 |
Why?
|
| RNA | 1 | 2005 | 171 | 0.020 |
Why?
|
| Cathepsin D | 1 | 2004 | 13 | 0.020 |
Why?
|
| Ligands | 1 | 2005 | 317 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 500 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2004 | 69 | 0.020 |
Why?
|
| Hybridomas | 1 | 2003 | 25 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 155 | 0.010 |
Why?
|
| Immunologic Tests | 1 | 2003 | 9 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2003 | 28 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2003 | 35 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2006 | 318 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 63 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 696 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2004 | 241 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2003 | 172 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 1032 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2003 | 142 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 258 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 397 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 714 | 0.010 |
Why?
|
| Breast | 1 | 2003 | 137 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2004 | 329 | 0.010 |
Why?
|
| Child | 1 | 2013 | 6400 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1745 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2003 | 368 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 945 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 595 | 0.010 |
Why?
|
| Apolipoprotein A-II | 1 | 1999 | 3 | 0.010 |
Why?
|
| Yolk Sac | 1 | 1999 | 10 | 0.010 |
Why?
|
| Apolipoprotein C-III | 1 | 1999 | 12 | 0.010 |
Why?
|
| Apolipoproteins C | 1 | 1999 | 15 | 0.010 |
Why?
|
| Apolipoprotein A-I | 1 | 1999 | 29 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 756 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1999 | 337 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2003 | 624 | 0.010 |
Why?
|
| Heymann Nephritis Antigenic Complex | 1 | 1997 | 3 | 0.010 |
Why?
|
| Clusterin | 1 | 1997 | 13 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1997 | 33 | 0.010 |
Why?
|
| Swine | 1 | 1997 | 672 | 0.010 |
Why?
|